TMCI logo

TMCITreace Medical Concepts Inc

$4.10
$0.50
(13.40%)
Today
Closed $4.23
$0.1308
(3.09%)
After Hours
Updated: 06:13 PM EDT
EarningsAug 6
Mkt Cap$241.98M
Vol744,792.00
News
all
press releases
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +9.68% and +2.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
More News
News Placeholder
Treace Medical Concepts (TMCI) to Release Earnings on Friday
Treace Medical Concepts (NASDAQ:TMCI) will be releasing its Q1 2026 earnings before the market opens on Friday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-8-treace-medical-concepts-inc-stock...
MarketBeat
News Placeholder
Weber Capital Management LLC ADV Invests $1.45 Million in Treace Medical Concepts, Inc. $TMCI
Weber Capital Management LLC ADV acquired a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 589,617 shares of the compa...
MarketBeat
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to Sell at Wall Street Zen
Wall Street Zen upgraded Treace Medical Concepts from a "strong sell" rating to a "sell" rating in a research note on Monday...
MarketBeat
News Placeholder
Wall Street Zen Downgrades Treace Medical Concepts (NASDAQ:TMCI) to Strong Sell
Wall Street Zen cut Treace Medical Concepts from a "sell" rating to a "strong sell" rating in a research note on Sunday...
MarketBeat
News Placeholder
Wall Street Zen Upgrades Treace Medical Concepts (NASDAQ:TMCI) to Sell
Wall Street Zen raised shares of Treace Medical Concepts from a "strong sell" rating to a "sell" rating in a report on Saturday...
MarketBeat
News Placeholder
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Reduce" from Analysts
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have received an average recommendation of "Reduce" from the seven ratings firms that are covering the firm, Marketbeat Ratings...
MarketBeat
News Placeholder
Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock?
Artivion (AORT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
News Placeholder
CIBC Bancorp USA Inc. Acquires New Stake in Treace Medical Concepts, Inc. $TMCI
CIBC Bancorp USA Inc. acquired a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen cut Treace Medical Concepts from a "hold" rating to a "sell" rating in a research note on Tuesday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.